BMS Archives - Journal for Clinical Studies

Regional News

Bristol Myers Squibb’s Opdivo posts another win in early lung cancer, but debate over treatment approach likely remains

Bristol Myers Squibb has expanded Opdivo’s first-in-class win in pre-surgery non-small cell lung cancer, teeing up a potential FDA filing. Opdivo added to chemothera...

10 November 2021 Regional News BMS | Bristol Myers Squibb

Continue Reading →

Regional News

Bristol Myers Squibb, after passing on Acceleron, now eyes Aurinia takeout: Bloomberg

It wasn't long ago that Bristol Myers Squibb ran the numbers on potentially buying Acceleron Pharma, but that deal didn't come together, and the biotech eventually so...

26 October 2021 Regional News Acceleron | Acceleron Pharma

Continue Reading →

Regional News

CEOs of AbbVie, BMS, Lilly, GSK and more raise concerns about Washington’s intensifying drug-pricing push

As officials in Washington weigh contentious drug-pricing measures, there's even more evidence that pharma companies are worried about potential reform. In an open l...

16 September 2021 Regional News AbbVie | Biogen

Continue Reading →

Derisking FIH Integrated Strategies

Current Edition

Bristol Myers Squibb’s Opdivo posts another win in early lung cancer, but debate over treatment approach likely remains

Bristol Myers Squibb, after passing on Acceleron, now eyes Aurinia takeout: Bloomberg

CEOs of AbbVie, BMS, Lilly, GSK and more raise concerns about Washington’s intensifying drug-pricing push

Journal for Clinical Studies